ARTICLE | Clinical News
ARCHITECT Anti-CCP assay regulatory update
October 26, 2009 7:00 AM UTC
FDA granted 510(k) clearance for Axis-Shield's antibody cyclic-citrulinated peptide (anti-CCP) assay to aid in the diagnosis of rheumatoid arthritis for use on the Architect i1000SR and i2000SR immuno...